Welcome to our dedicated page for Alphatec Hldgs SEC filings (Ticker: ATEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused medical device company. ATEC uses current reports on Form 8-K to furnish press releases on topics such as quarterly financial results, material corporate events, and board matters. For example, recent 8-K filings reference press releases announcing financial results for periods ended June 30 and September 30, 2025, as well as a release regarding the passing of a member of the Board of Directors.
In addition to 8-Ks, investors typically review ATEC’s annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed discussions of its spine surgery business, revenue composition (including surgical and EOS revenue), non-GAAP metrics such as adjusted EBITDA and free cash flow, and risk factors. These periodic reports also describe the company’s Organic Innovation Machine™, InformatiX™ and AlphaInformatiX platforms, and its focus on procedural spine ecosystems.
Regulatory filings can also reflect strategic and capital structure developments, such as refinancings of convertible debt, transaction-related expenses, and non-GAAP adjustments for items like litigation-related expenses, stock-based compensation, and restructuring costs. Forms 3, 4, and 5, when filed, provide insight into insider equity transactions by directors, officers, and significant shareholders.
On Stock Titan, ATEC’s SEC filings are updated in near real time as they are posted to EDGAR. AI-powered summaries help explain the key points of lengthy documents, highlighting items such as revenue trends, segment performance, non-GAAP reconciliations, and notable risk disclosures. For complex filings like 10-Ks and 10-Qs, the AI tools surface essential information so users can quickly understand how Alphatec’s spine-focused strategy, financial profile, and regulatory disclosures are evolving without reading every page.
Miles Patrick, CEO and Director of Alphatec Holdings, Inc. (ATEC), reported an insider transaction on 08/14/2025. The filing shows a sale of 10,000 common shares and discloses beneficial ownership following the transaction of 5,864,078 shares directly, plus 10,900 shares held in an IRA and 250,000 shares held indirectly by MOM, LLC. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.
Alphatec Holdings, Inc. filed a Form 144 reporting a proposed sale of 15,625 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $245,625. The sale is listed for execution approximately on 08/13/2025 on NASDAQ, against a total of 147,983,775 shares outstanding.
The securities were acquired on 02/24/2023 as 7,011 Performance Stock Units and 8,614 Restricted Stock Units, which together equal the 15,625 shares proposed for sale. The filing also discloses prior sales in the past three months totaling 152,688 shares for gross proceeds of approximately $1,971,447.50, several of which are identified as 10b5-1 plan transactions. The filer attests to no undisclosed material adverse information in connection with the notice.
Alphatec Holdings (ATEC) – Form 4: EVP, People & Culture Craig E. Hunsaker disclosed two open-market sales executed under a pre-arranged Rule 10b5-1 plan adopted 5-Mar-2025.
- 08-Aug-2025: Sold 50,000 common shares at a weighted avg. price of $15.00.
- 09-Aug-2025: Sold 10,876 common shares at $15.33.
After the transactions, Hunsaker directly owns 1,389,142 ATEC shares, down from roughly 1.45 million. The sales represent about 4.2 % of his direct stake.
No derivative security activity was reported. The filing contains no new operational or financial guidance; it solely documents the insider’s change in beneficial ownership.
Form 144 filing for Alphatec Holdings, Inc. (ATEC)
The filing discloses a proposed sale of 18,092 common shares with an aggregate market value of $269,688.68, scheduled for 08/05/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The securities were acquired on 08/05/2025 as restricted stock vesting under a registered plan and payment is listed as compensation. The filing also reports prior sales by the same person in the past three months: 12,878 shares on 08/01/2025 (gross proceeds $154,016.00) and 1,500 shares on 07/10/2025 (gross proceeds $17,936.00).
Administrative note: Filer identification fields (CIK/CCC/name) are not populated in the provided text.
What this filing shows
The filing notifies a proposed sale of 16,666 Alphatec Holdings (ATEC) common shares by an insider through Morgan Stanley Smith Barney, with an aggregate market value of $247,823.42. The sale is slated for 08/05/2025 on NASDAQ.
Why it matters
The shares being sold were granted as performance stock units (8,624) and restricted stock units (8,042). The filer, Scott Lish, has completed multiple recent sales under trading plans, totaling 136,022 shares sold in the past three months for gross proceeds of $1,721,457.50. This is a disclosure of insider liquidity events and shows pre-planned sales activity rather than new purchases.
FAQ
What is the current stock price of Alphatec Hldgs (ATEC)?
What is the market cap of Alphatec Hldgs (ATEC)?
